AstraZeneca PLC Ordinary Shares$161.54NVS · NYSE
The supplied consensus is Hold across 11 analysts, with a mean target of $147; low and high targets are unavailable. At the reported ending price of $153.27, that mean sits below the shares, but the evidence does not identify the analysts who are most or least bullish. Published snippets show a wide, inconsistent set of reference points, including $123.67 from StockAnalysis, $141.20 from MarketBeat, $155.37 from another StockAnalysis page, $159.00 from TipRanks and $158.20 from ChartMill. No attributable rating revisions are supplied for the past week, so the direction of estimate changes and the substantive analyst disagreement cannot be established beyond valuation dispersion.
